24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care

6. Crown Lengthening Surgery and the Supracrestal Tissue Attachment

The Supracrestal Tissue Attachment (Biological Width)

Originally defined by Gargiulo et al. (1961) and renamed Supracrestal Tissue Attachment in the 2018 Classification, this represents the physiological soft tissue seal situated coronal to the alveolar bone crest.

Supracrestal Tissue Attachment (Biological Width) Dimensions

  Gingival Margin
         │
         ├── Gingival Sulcus: ~ 0.69 mm (Histological sulcular depth)
         │
  Base of Sulcus
         │ ──┐
         │   ├── Junctional Epithelial Attachment: ~ 0.97 mm
         │   │   (Hemidesmosomal seal)
         │   │
  CEJ ───┤ ──┤                                          TOTAL SUPRACRESTAL
         │   │                                          TISSUE ATTACHMENT
         │   ├── Connective Tissue Attachment: ~ 1.07 mm     ~ 2.04 mm
         │   │   (Sharpey's collagen fibres inserting
         │   │    into acellular root cementum)
         │ ──┘
  Alveolar Bone Crest

• Junctional Epithelium: Mean height of $0.97\text{ mm}$.
• Connective Tissue Attachment: Mean height of $1.07\text{ mm}$.
• Total Supracrestal Tissue Attachment: $0.97\text{ mm} + 1.07\text{ mm} \approx 2.04\text{ mm}$.
• The Restorative Margin Rule: In restorative dentistry, the physiological gingival sulcus (~0.69–1.0 mm) must also be accommodated. Therefore, a minimum biological distance of $3.0\text{ mm}$ (ideally $3.5-4.0\text{ mm}$) must exist between the planned crown restorative margin and the underlying alveolar bone crest.

Pathological Consequences of Biological Width Violation

When a clinician prepares a tooth for an indirect restoration and places the margin within the supracrestal connective tissue attachment (less than 3 mm from the alveolar crest), the host responds with chronic pathology:

1. Persistent, intractable gingival inflammation and spontaneous bleeding refractory to oral hygiene.
2. Tissue hyperplasia, pocket deepening, or unpredictable gingival recession.
3. Alveolar bone resorption: The host osteoclasts resorb the alveolar bone crest apically until the physiological 2.04 mm biological width has been re-established away from the irritant foreign restorative margin.

Surgical Crown Lengthening Protocol

Surgical crown lengthening resolves biological width encroachment caused by deep subgingival caries, subgingival fractures, or short clinical crowns requiring mechanical ferrule. It involves elevating a full-thickness mucoperiosteal flap and executing ostectomy (resecting alveolar bone) to ensure the crest lies strictly >= 3.0 mm apical to the anticipated final restorative finish line**, establishing a solid $1.5-2.0 ext{ mm}$ parallel dentine ferrule above the margin.

7. Step 4: Supportive Periodontal Care (SPC)

Following successful completion of active therapy, all periodontitis patients enter Supportive Periodontal Care (SPC) for life. Periodontitis is a chronic disease that cannot be cured, but can be maintained in stability.

• Recall Frequencies: Dictated by individual risk profiling (e.g., the Lang and Tonetti Periodontal Risk Assessment [PRA] model evaluating BOP percentage, residual pockets $\ge 5\text{ mm}$, tooth loss, bone loss/age ratio, smoking, and diabetes):
  • Low Risk: Recall every 6 months.
  • Moderate Risk: Recall every 4 months.
  • High Risk: Recall every 3 months.
• SPC Clinical Protocol: Review medical history and risk factors; reinforce bespoke OHI; record updated plaque and bleeding scores; perform selective probing; execute targeted subgingival debridement (PMPR) strictly at sites with persistent bleeding, calculus, or pocketing $\ge 4\text{ mm}$.

8. Clinical Traps, Pitfalls, and Worked Scenarios

[!CAUTION] Clinical Trap: The Over-Aggressive Root Planing Fallacy: An operator spends 45 minutes vigorously scaling a single molar root with sharp curettes until a glassy, polished surface is achieved, removing all cementum down to middle dentine. The patient returns two weeks later complaining of excruciating sensitivity to cold and tactile contact. Histological studies confirm that bacterial lipopolysaccharides do not invade deeply into sound cementum; aggressive cementum removal produces no clinical benefit, strips away Sharpey's fibres necessary for repair, and opens thousands of dentinal tubules. Modern debridement must be measured and conservative.

[!WARNING] Clinical Trap: Performing Crown Preparation Without Biological Width Clearance: A fractured maxillary lateral incisor has only 0.5 mm of tooth structure remaining supragingivally on the palatal aspect. The clinician preps the finish line 1.5 mm subgingivally, sitting 1.0 mm away from the bone crest, and cements a porcelain crown. Within six months, the palatal margin presents with chronic, profuse bleeding, a 6 mm pseudopocket, and radiographic crestal bone loss. Placing margins inside the 2.04 mm supracrestal attachment triggers chronic osteoclastogenesis. Surgical crown lengthening with ostectomy was mandatory prior to final impression and crown fabrication.

Worked Clinical SBA Scenario

Scenario: A 42-year-old non-smoker attends for re-evaluation 10 weeks following Step 2 root surface debridement for Stage III Grade B periodontitis. Full-mouth plaque score is 15%, and full-mouth bleeding score is 8%. All periodontal sites demonstrate pocket closure (PPD $\le 4\text{ mm}$ without BOP), except for tooth 46. Probing on the mesio-buccal aspect of 46 reveals a persistent pocket depth of 7 mm with profuse bleeding on probing and suppuration. A calibrated periapical radiograph confirms an isolated, deep 6 mm intrabony defect on the mesial aspect of 46. Surgical flap exploration reveals that the defect is completely enclosed by three intact cortical bone walls (mesial, buccal, and lingual).

Question: What is the definitive, evidence-based surgical management protocol indicated for tooth 46, and what biological material provides optimal regenerative potential?

Clinical Reasoning Formulation:

1. Patient Suitability: The patient demonstrates excellent oral hygiene with an FMPS of $15%$ ($< 20%$) and an FMBS of $8%$ ($< 30%$), fulfilling all prerequisite criteria for Step 3 advanced surgical periodontal therapy.
2. Defect Anatomy: The defect is an isolated, deep ($\ge 3\text{ mm}$) vertical defect surrounded by three intact bony walls (3-wall intrabony defect).
3. Regenerative Suitability: Among all infrabony defect morphologies, 3-wall defects offer the highest regenerative predictability because the three intact osseous walls provide stable structural containment for the blood clot, prevent flap collapse, and offer an abundance of osteogenic and PDL progenitor cells from the adjacent vascular bone.
4. Therapeutic Protocol: The treatment of choice is Regenerative Periodontal Surgery using Enamel Matrix Derivative (EMD / Emdogain), optionally combined with an osteoconductive bone graft (e.g., deproteinized bovine bone mineral). Following careful surgical debridement and root conditioning with 24% EDTA to remove the smear layer, EMD is applied to the root surface to stimulate cementoblastogenesis and true periodontal attachment formation.